About: DorsaVi Limited

Overview:
DorsaVi Ltd (ASX: DVL) is an Australian-based med-tech company that has historically focused on biomechanical sensor solutions for clinical, sports, and occupational safety applications. The company’s proprietary wearable motion sensors, combined with data analytics, enable real-time measurement of human movement. DorsaVi transformed its strategy by acquiring exclusive global rights to a breakthrough memory technology developed by Nanyang Technological University (NTU), Singapore – Resistive Random Access Memory (RRAM). This pivot has repositioned DorsaVi as a hybrid medtech and deep-tech company, targeting high-margin opportunities in semiconductor IP, edge computing, and embedded AI applications.

Key Products and Technologies

DorsaVi Becomes a Robotics Company: Neuromorphic Reflex Platform Powered by RRAM

DorsaVi is no longer just a wearable sensor company. It is now making a bold move to become a robotics-first technology company. At the centre of this transformation is its exclusive license to advanced Resistive RAM (RRAM) technology from NTU Singapore, which underpins DorsaVi’s next-generation robotics reflex platform.

The company’s mission now focuses on improving how robots sense and react. DorsaVi’s RRAM-powered systems are designed to deliver ultra-fast, low-power reflexes, essential for the next wave of collaborative robots, prosthetics, and autonomous machines.

Engineered for Robotics Reflex: RRAM enables sub-millisecond response times, already demonstrated in robotic use cases such as soft grippers, exosuits, and mobile robots. These systems detect contact and react faster than traditional safety systems, offering better protection and control.

Share Price: 0.0320

ASX: DVL
Sector: Technology
05 August 2025

ASX: DVL Share price (A$)

Robotics Platform Evaluation Underway: In July 2025, DorsaVi began a full technical and commercial evaluation of its “reflex silicon” under robotic conditions. Testing includes measuring latency, actuator control, and power efficiency. Results from this evaluation are expected within four weeks.

Targeted Robotic Applications

  • Fast slip detection and grip control in robotic hands
  • Reflex motor control for robotic arms and humanoid machines
  • On-device EMG and ECG processing for prosthetics and assistive wearables
  • Smarter, quicker decision-making in mobile robots

Neuromorphic Computing at the Edge: The RRAM architecture supports analog matrix–vector multiplication, which allows realtime decision-making right where sensing happens. This is critical for robots that need fast, accurate reflexes.

Built for Efficiency: The platform runs on microwatt-level power and wakes up instantly when needed, ideal for battery-powered, always-on robotic and wearable systems.

Manufacturing-Ready: DorsaVi’s RRAM has been validated on 40nm CMOS with GlobalFoundries, making it suitable for integration into commercial ASICs and robotics systems today.

This shift in strategy marks a clear move. DorsaVi is committing to the future of robotics, with embedded intelligence and patented technology designed to improve safety, control, and performance across a broad range of robotic platforms.